Gajendra Kumar Azad Selected Research

Gajendra Kumar Azad Research Topics

8	COVID-19 01/2022 - 01/2020
3	Hypersensitivity (Allergy) 09/2014 - 01/2014
3	Neoplasms (Cancer) 08/2014 - 03/2014
2	Thrombocytopenia (Thrombopenia) 11/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 07/2021 - 01/2021
1	Pneumonia (Pneumonitis) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2021
1	Thrombosis (Thrombus) 01/2021
1	Nervous System Diseases (Neurological Disorders) 11/2016
1	Genomic Instability 01/2015
1	Stroke (Strokes) 08/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2014
1	Arthritis (Polyarthritis) 08/2014
1	Atherosclerosis 08/2014
1	Starvation 01/2013

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2014
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2014
2	VaccinesIBA 11/2021 - 01/2021
2	Superoxide DismutaseIBA 09/2014 - 01/2014
2	indazolium trans- (tetrachlorobis(1H- indazole)ruthenate (III))IBA 08/2014 - 03/2014
1	InterferonsIBA 01/2022
1	InterleukinsIBA 01/2022
1	Viral AntigensIBA 01/2022
1	CytokinesIBA 01/2022
1	InflammasomesIBA 01/2022
1	Lipid NanoparticlesIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	PhosphoproteinsIBA 02/2021
1	COVID-19 VaccinesIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	RutheniumIBA 08/2014
1	ebselenIBA 08/2014
1	IronIBA 01/2013
1	CurcuminIBA 01/2013